Jennifer R Rider

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi request reprint Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study
    Jennifer R Rider
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Eur Urol 63:88-96. 2013
  2. pmc Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue
    Mara M Epstein
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
    Cancer Causes Control 23:1359-66. 2012
  3. pmc Temporal trends in cause of death among Swedish and US men with prostate cancer
    Mara M Epstein
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Ave, 9th Floor, Boston, MA 02115, USA
    J Natl Cancer Inst 104:1335-42. 2012
  4. pmc The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis
    Andreas Pettersson
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Cancer Epidemiol Biomarkers Prev 21:1497-509. 2012
  5. pmc Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study
    Kathryn M Wilson
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    J Natl Cancer Inst 103:876-84. 2011
  6. pmc Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer
    Preet K Dhillon
    Channing Laboratory, Brigham and Women s Hospital and Harvard Medical School Boston, MA, USA
    Cancer Epidemiol Biomarkers Prev 20:2618-27. 2011

Collaborators

Detail Information

Publications6

  1. doi request reprint Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study
    Jennifer R Rider
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Eur Urol 63:88-96. 2013
    ..Limited data exist on long-term outcomes among men with prostate cancer (PCa) from population-based cohorts incorporating information on clinical risk category...
  2. pmc Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue
    Mara M Epstein
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
    Cancer Causes Control 23:1359-66. 2012
    ..As serum vitamin D levels vary by season, we sought to determine whether the expression of genes on the vitamin D pathway, assessed in prostate tumor tissue, do the same...
  3. pmc Temporal trends in cause of death among Swedish and US men with prostate cancer
    Mara M Epstein
    Department of Epidemiology, Harvard School of Public Health, 677 Huntington Ave, 9th Floor, Boston, MA 02115, USA
    J Natl Cancer Inst 104:1335-42. 2012
    ..Temporal trends in specific causes of death among prostate cancer patients have not been well described...
  4. pmc The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis
    Andreas Pettersson
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Cancer Epidemiol Biomarkers Prev 21:1497-509. 2012
    ..Whether the genomic rearrangement transmembrane protease, serine 2 (TMPRSS2):v-ets erythroblastosis virus E26 oncogene homolog (ERG) has prognostic value in prostate cancer is unclear...
  5. pmc Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study
    Kathryn M Wilson
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    J Natl Cancer Inst 103:876-84. 2011
    ..Because of these biological activities, coffee may be associated with a reduced risk of prostate cancer...
  6. pmc Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer
    Preet K Dhillon
    Channing Laboratory, Brigham and Women s Hospital and Harvard Medical School Boston, MA, USA
    Cancer Epidemiol Biomarkers Prev 20:2618-27. 2011
    ..However, the role of genetic variation in the adiponectin (ADIPOQ) and receptor genes (ADIPOR1/R2) in prostate cancer is largely unknown...